3rd Quarter - Report

HOOPER, LUNDY & BOOKMAN, P.C. for AVANIR PHARMACEUTICALS, INC.

Firm
Client
Income
$60,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FDA labeling of pharmaceutical, general pharmaceutical issues and monitoring of 21st Century Cures Act (H.R. 6) and Innovation for Healthier Americans initiative.

LobbyistCovered position, as disclosed
MARTIN A CORRY —
KELLY L. DELMORE Legislative Assistant; Office of Phil English
MONICA MASSARO —

Contacted: Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE

Bills named: H.R. 6 (114th)

Medicare/Medicaid MMM

General Medicare coverage of pharmaceutical drugs and Medicare quality programs. Medicare specialty tier cap increase.

LobbyistCovered position, as disclosed
MARTIN A CORRY —
KELLY L. DELMORE Legislative Assistant; Office of Phil English
MONICA MASSARO —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.